Association of ABCB1, μ-opioid Receptor, and Cytochrome P450 Genes with Methadone Dose in Iranian Male Addicts Under Methadone Therapy.

IF 1.1 Q4 NEUROSCIENCES
Abdollah Golnezhad, Anahita Torkaman-Boutorabi, Emran Mohammad Razaghi, Mohammad Reza Zarrindast, Mohammad Reza Mahdavi, Nasim Vousooghi
{"title":"Association of <i>ABCB1</i>, μ-opioid Receptor, and Cytochrome <i>P450</i> Genes with Methadone Dose in Iranian Male Addicts Under Methadone Therapy.","authors":"Abdollah Golnezhad, Anahita Torkaman-Boutorabi, Emran Mohammad Razaghi, Mohammad Reza Zarrindast, Mohammad Reza Mahdavi, Nasim Vousooghi","doi":"10.32598/bcn.2023.2756.2","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Treatment of opioid use disorders (OUDs) via safe and effective approaches has been investigated for years. Methadone maintenance treatment (MMT) has been considered an effective therapy for opioid addiction. It has been observed that patients with genetic polymorphisms often show variability in the optimal drug dose requirement and treatment schedule. This study aimed to investigate the relationship between single nucleotide polymorphisms (SNPs) in the ATP-binding cassette subfamily B member-1 (<i>ABCB1</i>), the mu-opioid receptor (<i>OPRM1</i>), and <i>cytochrome P450</i> (CYP) genes and methadone dose in patients undergoing MMT in Mazandaran Province, Iran.</p><p><strong>Methods: </strong>In a cross-sectional study, 216 male MMT patients (20 to 45 years old) who were involved in the treatment program for at least three months were randomly recruited from six MMT clinics in Mazandaran province between 2018 and 2020. Blood samples were taken, DNA was extracted, and SNPs of <i>CYP2B6</i> (G<sup>516</sup>T, A<sup>785</sup>G), <i>CYP2C19</i> (-3402C>T), <i>CYP3A4</i> (-392A>G), <i>OPRM</i> (A<sup>118</sup>G), and <i>ABCB1</i> (C<sup>3435</sup>T, G<sup>2677</sup>T, G<sup>2677</sup>A, and C<sup>1236</sup>T) genes were evaluated using polymerase chain reaction-restriction fragment length polymorphism (RFLP).</p><p><strong>Results: </strong>Our results showed no significant relationship between all the studied genotypes and methadone dose requirements.</p><p><strong>Conclusion: </strong>The present study, for the first time in the Mazandaran population, reported no significant correlations between methadone dose requirement and different SNPs in the <i>ABCB1</i>, <i>OPRM1</i>, and <i>CYP</i> genes in MMT patients, which is consistent with other studies conducted on the Iranian population.</p>","PeriodicalId":8701,"journal":{"name":"Basic and Clinical Neuroscience","volume":"15 5","pages":"703-712"},"PeriodicalIF":1.1000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198743/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic and Clinical Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32598/bcn.2023.2756.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Treatment of opioid use disorders (OUDs) via safe and effective approaches has been investigated for years. Methadone maintenance treatment (MMT) has been considered an effective therapy for opioid addiction. It has been observed that patients with genetic polymorphisms often show variability in the optimal drug dose requirement and treatment schedule. This study aimed to investigate the relationship between single nucleotide polymorphisms (SNPs) in the ATP-binding cassette subfamily B member-1 (ABCB1), the mu-opioid receptor (OPRM1), and cytochrome P450 (CYP) genes and methadone dose in patients undergoing MMT in Mazandaran Province, Iran.

Methods: In a cross-sectional study, 216 male MMT patients (20 to 45 years old) who were involved in the treatment program for at least three months were randomly recruited from six MMT clinics in Mazandaran province between 2018 and 2020. Blood samples were taken, DNA was extracted, and SNPs of CYP2B6 (G516T, A785G), CYP2C19 (-3402C>T), CYP3A4 (-392A>G), OPRM (A118G), and ABCB1 (C3435T, G2677T, G2677A, and C1236T) genes were evaluated using polymerase chain reaction-restriction fragment length polymorphism (RFLP).

Results: Our results showed no significant relationship between all the studied genotypes and methadone dose requirements.

Conclusion: The present study, for the first time in the Mazandaran population, reported no significant correlations between methadone dose requirement and different SNPs in the ABCB1, OPRM1, and CYP genes in MMT patients, which is consistent with other studies conducted on the Iranian population.

美沙酮治疗伊朗男性依赖者ABCB1、μ-阿片受体和细胞色素P450基因与美沙酮剂量的关系
前言:通过安全有效的方法治疗阿片类药物使用障碍(OUDs)已经研究多年。美沙酮维持治疗(MMT)被认为是治疗阿片类药物成瘾的有效方法。据观察,具有遗传多态性的患者通常在最佳药物剂量需求和治疗计划方面表现出可变性。本研究旨在探讨伊朗Mazandaran省MMT患者中atp结合盒亚家族B成员-1 (ABCB1)、mu-阿片受体(OPRM1)和细胞色素P450 (CYP)基因的单核苷酸多态性(snp)与美沙酮剂量的关系。方法:在一项横断面研究中,从2018年至2020年Mazandaran省的6家MMT诊所随机招募了216名参与治疗方案至少三个月的男性MMT患者(20至45岁)。采集血样,提取DNA,采用聚合酶链反应限制性片段长度多态性(RFLP)技术检测CYP2B6 (G516T、A785G)、CYP2C19 (-3402C>T)、CYP3A4 (-392A>G)、OPRM (A118G)和ABCB1 (C3435T、G2677T、G2677A和C1236T)基因的snp。结果:我们的研究结果显示,所有研究基因型与美沙酮剂量需求之间没有显著关系。结论:本研究首次在Mazandaran人群中报道美沙酮剂量需求与MMT患者ABCB1、OPRM1和CYP基因的不同snp之间无显著相关性,这与在伊朗人群中进行的其他研究一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.60
自引率
0.00%
发文量
64
审稿时长
4 weeks
期刊介绍: BCN is an international multidisciplinary journal that publishes editorials, original full-length research articles, short communications, reviews, methodological papers, commentaries, perspectives and “news and reports” in the broad fields of developmental, molecular, cellular, system, computational, behavioral, cognitive, and clinical neuroscience. No area in the neural related sciences is excluded from consideration, although priority is given to studies that provide applied insights into the functioning of the nervous system. BCN aims to advance our understanding of organization and function of the nervous system in health and disease, thereby improving the diagnosis and treatment of neural-related disorders. Manuscripts submitted to BCN should describe novel results generated by experiments that were guided by clearly defined aims or hypotheses. BCN aims to provide serious ties in interdisciplinary communication, accessibility to a broad readership inside Iran and the region and also in all other international academic sites, effective peer review process, and independence from all possible non-scientific interests. BCN also tries to empower national, regional and international collaborative networks in the field of neuroscience in Iran, Middle East, Central Asia and North Africa and to be the voice of the Iranian and regional neuroscience community in the world of neuroscientists. In this way, the journal encourages submission of editorials, review papers, commentaries, methodological notes and perspectives that address this scope.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信